Explore more publications!
Oklahoma Healthcare Wire
Got News to Share?

Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 20, 2026

Moonbird Claims Evaluated: Guided Breathing Therapy Device for Meditation-Like Calming Benefits for Relaxation & Sleep Support
Apr. 20, 2026

Moonbird Claims Evaluated: Guided Breathing Therapy Device for Meditation-Like Calming Benefits for Relaxation & Sleep Support

Indeterminate GlobeNewswire
Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定，并通过 IND 审评
Apr. 20, 2026

Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定，并通过 IND 审评

Indeterminate GlobeNewswire
Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee
Apr. 20, 2026

Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee

Indeterminate GlobeNewswire
Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor Immunotherapy
Apr. 20, 2026

Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor Immunotherapy

Indeterminate GlobeNewswire
AKTUALISIERUNG -- BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat
Apr. 20, 2026

AKTUALISIERUNG -- BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat

Indeterminate GlobeNewswire
MISE À JOUR -- BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction
Apr. 20, 2026

MISE À JOUR -- BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction

Indeterminate GlobeNewswire
BastionGPT Named Top AI Platform for Clinical Psychology Report Writing
Apr. 20, 2026

BastionGPT Named Top AI Platform for Clinical Psychology Report Writing

Indeterminate GlobeNewswire
Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026
Apr. 20, 2026

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026

Indeterminate GlobeNewswire
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
Apr. 20, 2026

CVRx Announces Nomination of Michael Dale for Election to the Board of Directors

Indeterminate GlobeNewswire
JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering
Apr. 20, 2026

JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering

Indeterminate GlobeNewswire
Spectral AI Announces Annual Meeting of Stockholders
Apr. 20, 2026

Spectral AI Announces Annual Meeting of Stockholders

Indeterminate GlobeNewswire
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
Apr. 20, 2026

SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026

Indeterminate GlobeNewswire
BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma
Apr. 20, 2026

BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
Apr. 20, 2026

Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents

Indeterminate GlobeNewswire
Regeneron Announces Investor Conference Presentations
Apr. 20, 2026

Regeneron Announces Investor Conference Presentations

Indeterminate GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr. 20, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
Apr. 20, 2026

Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026

Indeterminate GlobeNewswire
Amwell® to report first quarter 2026 operating results
Apr. 20, 2026

Amwell® to report first quarter 2026 operating results

Indeterminate GlobeNewswire
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
Apr. 20, 2026

Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event
Apr. 20, 2026

Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions